Edition:
United States

Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

280.00DKK
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
kr.280.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,327,216
52-wk High
kr.354.80
52-wk Low
kr.265.15

Select another date:

Mon, Oct 15 2018

Photo

Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit

COPENHAGEN Novo Nordisk is in advanced talks to acquire assets to bolster its struggling biopharma business, its chief executive said on Monday after the drugmaker announced it had hired an AstraZeneca executive to head the unit.

UPDATE 1-Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit

COPENHAGEN, Oct 15 Novo Nordisk is in advanced talks to acquire assets to bolster its struggling biopharma business, its chief executive said on Monday after the drugmaker announced it had hired an AstraZeneca executive to head the unit.

Novo Nordisk could close biopharma acquisition this year -CEO

COPENHAGEN, Oct 15 Novo Nordisk might be able to complete an acquisition within its struggling biopharma business this year, its chief executive told Reuters on Monday.

Novo Nordisk picks AstraZeneca executive to head biopharma business

COPENHAGEN, Oct 15 Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been struggling with declining sales and a failed acquisition.

Lilly's diabetes drug data impresses, hurts rival Novo's shares

Eli Lilly and Co said on Thursday its new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending its shares to a record high and weighing on those of arch-rival Novo Nordisk .

UPDATE 2-Lilly's diabetes drug data impresses, hurts rival Novo's shares

Oct 4 Eli Lilly and Co said on Thursday its new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending its shares to a record high and weighing on those of arch-rival Novo Nordisk .

BRIEF-Novo Nordisk Plans First Global Launch Of Connected Insulin Pens

* NOVO NORDISK PLANS FIRST GLOBALLAUNCH OF CONNECTED INSULIN PENS AND ANNOUNCES KEY DIGITAL HEALTH PARTNERSHIPS

Novo Nordisk to cut 250 jobs in the United States

COPENHAGEN Denmark's Novo Nordisk will cut around 250 jobs in the United States, a spokesman told Reuters on Friday, adding the drugmaker would also hire an as-yet undetermined number of staff to new positions.

UPDATE 1-Novo Nordisk to cut 250 jobs in the United States

COPENHAGEN, Sept 28 Denmark's Novo Nordisk will cut around 250 jobs in the United States, a spokesman told Reuters on Friday, adding the drugmaker would also hire an as-yet undetermined number of staff to new positions.

Novo Nordisk to cut 250 jobs in the United States

COPENHAGEN, Sept 28 Denmark's Novo Nordisk will cut around 250 jobs in the United States, a spokesman told Reuters on Friday. He said it would also hire some new staff in other positions but that the company did not know the number of new positions yet.

Select another date: